yttrium radioisotopes has been researched along with Venous Thrombosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 21 (72.41) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Boudousq, V; Desmarets, G; Fidani, T; Goupil, J; Pouget, JP | 1 |
| Cardarelli-Leite, L; Chou, F; Chung, J; Hadjivassiliou, A; Ho, S; Klass, D; Lim, H; Liu, DM; Marquez, V; Tae Wan Kim, P; Walton, H | 1 |
| Camacho, JC; Kim, HS; Kokabi, N; Xing, M | 1 |
| D'Angelo, R; Fiore, F; Gatta, G; Serra, N; Somma, F; Stoia, V | 1 |
| Lai, Q; Levi Sandri, GB; Lucatelli, P | 1 |
| Cho, EJ; Cho, HJ; Choi, NR; Hong, JH; Hur, MH; Hyun, D; Kim, HC; Kim, J; Kim, JM; Kim, JY; Kim, YJ; Lee, JH; Lee, KW; Lee, YB; Paeng, JC; Park, MK; Sinn, DH; Suh, KS; Yi, NJ; Yoon, JH; Yu, SJ | 1 |
| Abdalla, A; Abdallah, MA; Andrews, JC; Bampoh, S; Fleming, CJ; Glubranson, LA; Hassan, MA; Mahipal, A; Nelson, M; Onyirioha, K; Roberts, LR; Taha, W; Wiseman, GA; Wongjarupong, N | 1 |
| Ahn, SH; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Lee, HW; Park, JY; Seong, J; Song, JE; Song, K; Won, JY | 1 |
| Alessio, A; Kwan, SW; Lewis, DH; Minoshima, S; Padia, SA; Vaidya, S | 1 |
| Gates, VL; Lewandowski, RJ; Salem, R | 1 |
| Barron, BJ; Camacho, JC; Galt, JR; Kim, HS; Kokabi, N; Schuster, DM; Xing, M | 1 |
| Camacho, JC; Kim, HS; Kitajima, H; Kokabi, N; Mittal, PK; Qiu, D; Xing, M | 1 |
| Kafadar, C; Kara, K; Mutlu, H; Sivrioglu, AK | 1 |
| Erxleben, C; Gebauer, B; Geisel, D; Hamm, B; Heimann, U; Powerski, MJ; Scheurig-Münkler, C | 1 |
| Akyuz, F; Karaca, C; Keskin, S; Kuyumcu, S; Ozkan, ZG; Poyanli, A; Saglam, S; Turkmen, C; Ucar, A; Yilmaz, E | 1 |
| Camacho, JC; El-Rayes, BF; Kim, HS; Knechtle, SJ; Kokabi, N; Spivey, JR; Xing, M | 1 |
| Akinwande, O; Brown, R; Edwards, J; Kim, D; Martin, RC; Philips, P; Scoggins, C | 1 |
| Adhoute, X; Blanc, JF; Boucher, E; Boudjema, K; Campillo-Gimenez, B; Clément, B; Crouzet, L; Edeline, J; Garin, E; Guillygomarc'h, A; Lenoir, L; Pracht, M; Rohou, T; Rolland, Y | 1 |
| Angelelli, B; Ascanio, S; Bolondi, L; Cappelli, A; Galaverni, MC; Garzillo, G; Giampalma, E; Golfieri, R; Monari, F; Mosconi, C; Pettinato, C; Pini, P; Piscaglia, F; Renzulli, M; Terzi, E; Trevisani, F | 1 |
| Alshebeeb, K; Biederman, DM; Facciuto, ME; Fischman, AM; Florman, S; Gunasekaran, G; Kim, E; Nowakowski, FS; Patel, RS; Pierobon, ES; Schwartz, M; Tabori, NE; Titano, JJ | 1 |
| Bae, SH; Cho, YY; Chung, JW; Gwak, GY; Heo, J; Kim, do Y; Kim, HC; Kim, YH; Kim, YJ; Lee, M | 1 |
| Brun, V; Edeline, J; Garin, E; Haumont, LA; Laffont, S; Le Sourd, S; Lenoir, L; Mesbah, H; Pracht, M; Rohou, T; Rolland, Y | 1 |
| Bhoori, S; Ciani, O; Facciorusso, A; Mazzaferro, V; Rognoni, C; Sommariva, S; Tarricone, R | 1 |
| Ellis, SF; Hahl, MJ; Martin, RC; McMasters, KM; Ravindra, KV; Scoggins, CR; Tatum, CM; Woodall, CE | 1 |
| Andrews, JC; Fleming, CJ; Gansen, DN; Roberts, LR; Wiseman, GA | 1 |
| Bernard, SA; Burke, CT; Dixon, RD; Kennedy, AS; Khandani, AH; Mauro, MA; Moore, DT; O'Neil, BH; Stavas, JM; Tsai, AL | 1 |
| Benson, AB; Ganger, D; Gates, VL; Gupta, R; Kulik, L; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, MF; Omary, RA; Riaz, A; Salem, R; Vouche, M | 1 |
| Abouljoud, M; Courtney, A; Goin, J; Lewandowski, R; Roberts, C; Salem, R; Thurston, K | 1 |
| Abecassis, M; Atassi, B; Benson, A; Carr, BI; Gates, VL; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Nemcek, AA; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
1 review(s) available for yttrium radioisotopes and Venous Thrombosis
| Article | Year |
|---|---|
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease Progression; Humans; Liver Failure; Liver Neoplasms; Neoplasm Staging; Observational Studies as Topic; Portal Vein; Survival Rate; Time Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
4 trial(s) available for yttrium radioisotopes and Venous Thrombosis
| Article | Year |
|---|---|
Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Portal Vein; Quality of Life; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2018 |
Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Prospective Studies; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Venous Thrombosis; Yttrium Radioisotopes | 2009 |
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Middle Aged; Portal Vein; Treatment Outcome; United States; Venous Thrombosis; Yttrium Radioisotopes | 2008 |
24 other study(ies) available for yttrium radioisotopes and Venous Thrombosis
| Article | Year |
|---|---|
A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall?
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Thrombosis; Umbilical Veins; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2020 |
Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Portal Vein; Prognosis; Radionuclide Imaging; Survival Analysis; Venous Thrombosis; Yttrium Radioisotopes | 2019 |
The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Portal Vein; Retrospective Studies; Treatment Outcome; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2020 |
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease-Free Survival; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Propensity Score; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Portal Vein; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glass; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Portal Vein; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2014 |
Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2014 |
Apparent diffusion coefficient quantification as an early imaging biomarker of response for unresectable infiltrative hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Hepatopulmonary shunting in patients with primary and secondary liver tumors scheduled for radioembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Portal Vein; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portal Vein; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Sorafenib; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2015 |
Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
Topics: Aged; alpha-Fetoproteins; Aspartate Aminotransferases; Bilirubin; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Glass; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Invasiveness; New York City; Portal Vein; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Propensity Score; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sorafenib; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; France; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Logistic Models; Male; Microspheres; Middle Aged; Multivariate Analysis; Portal Vein; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Comorbidity; Female; Hepatic Veins; Humans; Incidence; Liver Neoplasms; Male; Microspheres; Middle Aged; Minnesota; Pulmonary Embolism; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2009 |
Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.
Topics: Adolescent; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; North Carolina; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2010 |
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Patient Selection; Portal Vein; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Portal Vein; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2004 |